Form 4 for BAX Baxter International

Accepted 2024-02-14 00:00:00 ET · period of report 2024-02-12 · accession 0001062993-24-003182 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2024-02-14	2024-02-12	BAX	Knight Heather	EVP, Group Pres, Med Products	F - Tax	$40.31	-356	56.6K	-0.6%	-$14.4K
	2024-02-14	2024-02-12	BAX	Knight Heather	EVP, Group Pres, Med Products	A - Grant	$0.00	+1,027	57.0K	+2%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, $1 par value	2024-02-12	F	D	356	$40.31	56,602	D	—	—	(F2) Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2021 PSUs. (F3) Totals include the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Purchase Plan. Totals have been updated to reflect an administrative error that excluded 1,121 shares of common stock that were held by Ms. Knight on the original Form 3 filed on March 3, 2023.
2	Common	Common Stock, $1 par value	2024-02-12	A	A	1,027	$0.00	56,958	D	—	—	(F1) Represents shares awarded from the performance share unit award granted on March 3, 2021 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2021 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2021 to December 31, 2023 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended.